QNTM · CIK 0001771885
Quantum BioPharma Ltd.
Annual figures as reported, FY2018–FY2025. Ratios and growth rates derived on-page.
Pharmaceutical Preparations
Company profile
Free cash flow
−$6.9M
▲ +36.5% vs FY2023
Total assets
$11.2M
▼ −34.8% vs FY2024
Cash flow
cash generationFree cash flow
Operating cash flow less capital expenditure
Operating cash flow
Net cash from operations
Shareholder returns
capital allocationDiluted shares outstanding
Falling count means buybacks outpace dilution
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Net debt
Long-term debt less cash — negative means net cash
Growth rates
compounding, annualizedShare count change (split-adjusted)
−83.9%
5y
Key ratios
derived per fiscal year| Fiscal year | Current ratio | Debt / equity |
|---|---|---|
| FY2025 | 1.07× | 0.25× |
| FY2024 | 1.80× | 0.06× |
| FY2023 | 2.43× | — |
| FY2022 | 2.28× | — |
| FY2021 | 5.28× | — |
| FY2020 | 4.82× | — |
| FY2019 | 12.55× | — |
| FY2018 | 12.94× | — |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | — | — | −$15.3M | — | — | −$8.2M | — | $11.2M | $6.1M | $5.1M | $1.9M | $1.3M |
| FY2024 | — | — | −$16.1M | — | — | −$6.9M | $0 | $17.1M | $6.7M | $10.4M | $6.0M | $619K |
| FY2023 | — | — | −$23.8M | — | — | −$10.8M | $0 | $17.5M | $4.6M | $12.9M | $2.8M | — |
| FY2022 | — | — | −$27.4M | — | — | −$28.3M | $114K | $38.4M | $7.9M | $30.5M | $17.0M | — |
| FY2021 | — | — | −$33.7M | — | — | −$20.7M | $0 | $63.0M | $8.8M | $54.1M | $35.3M | — |
| FY2020 | — | — | −$30.7M | — | — | −$19.1M | $0 | $42.0M | $5.7M | $36.3M | $17.5M | — |
| FY2019 | — | — | −$22.5M | — | — | −$13.7M | — | $39.9M | $1.5M | $38.4M | $15.9M | — |
| FY2018 | — | — | — | — | — | — | — | $39.7M | $1.3M | $38.4M | $15.9M | — |
Latest filings
the most recent regulatory filings6-KForeign issuer report2026-06-02 ↗6-KForeign issuer report2026-06-02 ↗6-KForeign issuer report2026-05-18 ↗6-KForeign issuer report2026-05-07 ↗6-KForeign issuer report2026-05-06 ↗6-KForeign issuer report2026-04-22 ↗6-KForeign issuer report2026-04-02 ↗6-KForeign issuer report2026-04-01 ↗6-KForeign issuer report2026-03-30 ↗6-KForeign issuer report2026-03-27 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.